Biology of Blood and Marrow Transplantation

1

Clinical Utility of Computed Tomography Screening of Chest, Abdomen, and Sinuses before Hematopoietic Stem Cell Transplantation: The St. Jude Experience

Kimberly A. Kasow, Jennifer Krueger, Deo Kumar Srivastava, Chenghong Li, Raymond Barfield, Wing Leung, Edwin M. Horwitz, Renee Madden, Paul Woodard, Ishtiaq Hussain, M. Beth McCarville, Rupert Handgre

Journal:

Year:

2009

Language:

english

File:

PDF, 299 KB

english, 2009

2

Immune Reconstitution following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: The Impact of Expanding CD28negative CD8+ T Cells on Relapse

Ibrahim Yakoub-Agha, Pasquine Saule, Leonardo Magro, Pascale Cracco, Alain Duhamel, Valérie Coiteux, Bénédicte Bruno, Françoise Dufossé, Jean-Pierre Jouet, Jean-Paul Dessaint, Myriam Labalette

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 241 KB

english, 2009

3

Nonabsorbable Corticosteroids Use in the Treatment of Gastrointestinal Graft-versus-Host Disease

Rami B. Ibrahim, Muneer H. Abidi, Simon M. Cronin, Lawrence G. Lum, Zaid Al-Kadhimi, Voravit Ratanatharathorn, Joseph P. Uberti

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 221 KB

english, 2009

4

First-Line Therapy for Chronic Graft-versus-Host Disease that Includes Low-Dose Methotrexate Is Associated with a High Response Rate

Yu Wang, Lan-ping Xu, Dai-hong Liu, Huan Chen, Yu-hong Chen, Wei Han, Kai-yan Liu, Xiao-Jun Huang

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 206 KB

english, 2009

5

Frequency of Abnormal Findings Detected by Comprehensive Clinical Evaluation at 1 Year after Allogeneic Hematopoietic Cell Transplantation

Stephanie J. Lee, Travis Seaborn, Frances J. Mao, Susan C. Massey, Ngoc Q. Luu, Mary A. Schubert, Jason W. Chien, Paul A. Carpenter, Carina Moravec, Paul J. Martin, Mary E.D. Flowers

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 118 KB

english, 2009

6

Nonengraftment Haploidentical Cellular Immunotherapy for Refractory Malignancies: Tumor Responses without Chimerism

Gerald A. Colvin, David Berz, Muthalagu Ramanathan, Eric S. Winer, Loren Fast, Gerald J. Elfenbein, Peter J. Quesenberry

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 554 KB

english, 2009

7

Induction of Graft-versus-Leukemia (GVL) Effect without Graft-versus-Host Disease (GVHD) by Pretransplant Donor Treatment with Immunomodulators

Shoshana Morecki, Elena Yacovlev, Yael Gelfand, Yehudit Shabat, Shimon Slavin

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 478 KB

english, 2009

8

Imipenem/Cilastatin with or without Glycopeptide as Initial Antibiotic Therapy for Recipients of Autologous Stem Cell Transplantation: Results of a Spanish Multicenter Study

Javier de la Rubia, Pau Montesinos, Rodrigo Martino, Isidro Jarque, Montserrat Rovira, Lourdes Vázquez, Javier López, Montserrat Batlle, Rafael de la Cámara, Antoni Juliá, Juan J. Lahuerta, Guillermo

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 128 KB

english, 2009

9

Allogeneic Stem Cell Transplantation Compared with Chemotherapy for Poor-Risk Hodgkin Lymphoma

Luca Castagna, Barbara Sarina, Elisabetta Todisco, Massimo Magagnoli, Monica Balzarotti, Stefania Bramanti, Rita Mazza, Antonella Anastasia, Andrea Bacigalupo, Franco Aversa, Davide Soligo, Laura Gior

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 224 KB

english, 2009

10

Incidence and Risk Factors of Early Bacterial Infections after Unrelated Cord Blood Transplantation

Makoto Yazaki, Yoshiko Atsuta, Koji Kato, Shunichi Kato, Shuichi Taniguchi, Satoshi Takahashi, Hiroyasu Ogawa, Yasuji Kouzai, Takeshi Kobayashi, Masami Inoue, Ryoji Kobayashi, Tokiko Nagamura-Inoue, H

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 168 KB

english, 2009

11

Carbon Monoxide Diffusion Capacity: How Low Can You Go for Hematopoietic Cell Transplantation Eligibility?

Jason W. Chien, Keith M. Sullivan

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 199 KB

english, 2009

12

Low-Dose Foscarnet Preemptive Therapy for Cytomegalovirus Viremia after Haploidentical Bone Marrow Transplantation

Hengxiang Wang, Ling Zhu, Mei Xue, Jing Liu, Zikuan Guo

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 82 KB

english, 2009

13

Does Extra Alemtuzumab Remove the Graft-versus-Leukemia Effect after Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia?

Bipin N. Savani, Stacey Goodman, Nishitha Reddy

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 95 KB

english, 2009

14

Complete Remission Status before Autologous Stem Cell Transplantation Is an Important Prognostic Factor in Patients with Multiple Myeloma Undergoing Upfront Single Autologous Transplantation

Jin Seok Kim, Kihyun Kim, June-Won Cheong, Yoo Hong Min, Cheolwon Suh, Hawk Kim, Deog Yeon Jo, Hun Mo Ryoo, Sung Soo Yoon, Jae Hoon Lee

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 279 KB

english, 2009

15

HLA-Mismatched Unrelated Donors as an Alternative Graft Source for Allogeneic Stem Cell Transplantation after Antithymocyte Globulin-Containing Conditioning Regimen

Nicolaus Kröger, Tatjana Zabelina, Thomas Binder, Francis Ayuk, Ulrike Bacher, Gitta Amtsfeld, Heinrich Lellek, Johanna Schrum, Rolf Erttmann, Thomas Eiermann, Axel Zander

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 335 KB

english, 2009

16

Peripheral Blood Eosinophilia Has a Favorable Prognostic Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation

Dong Hwan Kim, Gizelle Popradi, Wei Xu, Vikas Gupta, John Kuruvilla, Janice Wright, Hans A. Messner, Jeffrey H. Lipton

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 772 KB

english, 2009

17

A Retrospective Review of the Outcome after Second or Subsequent Allogeneic Transplantation

Meirav Kedmi, Igor B. Resnick, Liliane Dray, Memet Aker, Simcha Samuel, Benjamin Gesundheit, Shimon Slavin, Reuven Or, Michael Y. Shapira

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 280 KB

english, 2009

18

Erratum

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 55 KB

english, 2009

19

Erratum

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 55 KB

english, 2009

20

Masthead (Purpose and Scope)

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 85 KB

english, 2009

21

Editorial Board

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 65 KB

english, 2009

22

Officers and Directors of ASBMT

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 56 KB

english, 2009

23

Volume 15; Issue 4

Biology of Blood and Marrow Transplantation

Clinical Utility of Computed Tomography Screening of Chest, Abdomen, and Sinuses before Hematopoietic Stem Cell Transplantation: The St. Jude Experience

Immune Reconstitution following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: The Impact of Expanding CD28negative CD8+ T Cells on Relapse

Nonabsorbable Corticosteroids Use in the Treatment of Gastrointestinal Graft-versus-Host Disease

First-Line Therapy for Chronic Graft-versus-Host Disease that Includes Low-Dose Methotrexate Is Associated with a High Response Rate

Frequency of Abnormal Findings Detected by Comprehensive Clinical Evaluation at 1 Year after Allogeneic Hematopoietic Cell Transplantation

Nonengraftment Haploidentical Cellular Immunotherapy for Refractory Malignancies: Tumor Responses without Chimerism

Induction of Graft-versus-Leukemia (GVL) Effect without Graft-versus-Host Disease (GVHD) by Pretransplant Donor Treatment with Immunomodulators

Imipenem/Cilastatin with or without Glycopeptide as Initial Antibiotic Therapy for Recipients of Autologous Stem Cell Transplantation: Results of a Spanish Multicenter Study

Allogeneic Stem Cell Transplantation Compared with Chemotherapy for Poor-Risk Hodgkin Lymphoma

Incidence and Risk Factors of Early Bacterial Infections after Unrelated Cord Blood Transplantation

Carbon Monoxide Diffusion Capacity: How Low Can You Go for Hematopoietic Cell Transplantation Eligibility?

Low-Dose Foscarnet Preemptive Therapy for Cytomegalovirus Viremia after Haploidentical Bone Marrow Transplantation

Does Extra Alemtuzumab Remove the Graft-versus-Leukemia Effect after Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia?

Complete Remission Status before Autologous Stem Cell Transplantation Is an Important Prognostic Factor in Patients with Multiple Myeloma Undergoing Upfront Single Autologous Transplantation

HLA-Mismatched Unrelated Donors as an Alternative Graft Source for Allogeneic Stem Cell Transplantation after Antithymocyte Globulin-Containing Conditioning Regimen

Peripheral Blood Eosinophilia Has a Favorable Prognostic Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation

A Retrospective Review of the Outcome after Second or Subsequent Allogeneic Transplantation

Erratum

Erratum

Masthead (Purpose and Scope)

Editorial Board

Officers and Directors of ASBMT

Table of Contents